title: Inactivation of ceramide transfer protein during pro-apoptotic stress by Golgi disassembly and caspase cleavage.
abstract: The mammalian Golgi apparatus is composed of multiple stacks of cisternal membranes organized laterally into a polarized ribbon. Furthermore, trans-Golgi membranes come in close apposition with ER (endoplasmic reticulum) membranes to form ER-trans-Golgi contact sites, which may facilitate transfer of newly synthesized ceramide from the ER to SM (sphingomyelin) synthase at the trans-Golgi via CERT (ceramide transfer protein). CERT interacts with both ER and Golgi membranes, and together with Golgi morphology contributes to efficient SM synthesis. In the present study, we show that Golgi disassembly during pro-apoptotic stress induced by TNFα (tumour necrosis factor α) and anisomycin results in decreased levels of CERT at the Golgi region. This is accompanied by a caspase-dependent loss of full-length CERT and reduction in de novo SM synthesis. In vitro, CERT is cleaved by caspases 2, 3 and 9. Truncated versions of CERT corresponding to fragments generated by caspase 2 cleavage at Asp213 were mislocalized and did not promote efficient de novo SM synthesis. Thus it is likely that during cellular stress, disassembly of Golgi structure together with inactivation of CERT by caspases causes a reduction in ceramide trafficking and SM synthesis, and could contribute to the cellular response to pro-apoptotic stress.
authors: Department of Cell Biology, Johns Hopkins University School of Medicine, 725 N. Wolfe Street, Baltimore, MD 21205, U.S.A.
authors: Suchismita
authors: S
authors: Chandran
authors: Carolyn E
authors: CE
authors: Machamer
mesh_terms: D019943:Amino Acid Substitution; D017209:Apoptosis / Q000502:physiology*; D001224:Aspartic Acid / Q000737:chemistry; D001665:Binding Sites; D053143:Caspase 2 / Q000378:metabolism; D020169:Caspases / Q000378:metabolism*; D002518:Ceramides / Q000378:metabolism; D003546:Cysteine Endopeptidases / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000378:metabolism; D006056:Golgi Apparatus / Q000378:metabolism; D006367:HeLa Cells; D006801:Humans; D016297:Mutagenesis, Site-Directed; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D013109:Sphingomyelins / Q000378:metabolism; D013312:Stress, Physiological; D013379:Substrate Specificity
chemical_list: D002518:Ceramides; D011994:Recombinant Proteins; D013109:Sphingomyelins; D001224:Aspartic Acid; C119090:CERT1 protein, human; D017346:Protein Serine-Threonine Kinases; C490360:CASP2 protein, human; D053143:Caspase 2; D020169:Caspases; D003546:Cysteine Endopeptidases